期刊
RHEUMATOLOGY
卷 50, 期 1, 页码 16-24出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq155
关键词
NDB; Registry; Data Bank; National Data Bank for rheumatic diseases
类别
资金
- Bristol Myers Squibb
- UCB
- Pfizer
The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据